Skip to main content

Phenobarbital

  • Chapter
  • First Online:
Antiepileptic Drug Interactions
  • 1422 Accesses

Abstract

BCNU does not affect the ­pharmacokinetics of phenobarbital [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Grossman SA, Sheidler VR, Gilbert MR. Decreased phenytoin levels in patients receiving chemotherapy. Am J Med. 1989;87:505–10.

    Article  PubMed  CAS  Google Scholar 

  2. Fincham RW, Schottelius DD. Decreased phenytoin levels in antineoplastic therapy. Ther Drug Monit. 1979;1:277–83.

    Article  PubMed  CAS  Google Scholar 

  3. Koup JR. Interaction of chloramphenicol with phenytoin and phenobarbital. A case report. Clin Pharmacol Ther. 1978;24:393–402.

    Google Scholar 

  4. Cucinell SA, Conney AH, Sansur MS, Burns JJ. Drug interactions in man. I. Lowering effect of phenobarbital on plasma levels of bishydroxycoumarin (Dicoumarol®) and diphenylhydantoin (Dilantin®). Clin Pharmacol Ther. 1965;6:420–9.

    PubMed  CAS  Google Scholar 

  5. Olesen OV. The influence of disulfiram and calcium carbimide on the serum diphenylhydantoin. Excretion of HPPH in the urine. Arch Neurol. 1967;16:642–4.

    Article  PubMed  CAS  Google Scholar 

  6. Greendyke RM, Gulya A. Effect of pindolol administration on serum levels of thioridazine, haloperidol, phenytoin, and phenobarbital. J Clin Psychiatry. 1988;49:105–7.

    PubMed  CAS  Google Scholar 

  7. Hansen SB, Dam M, Brandt J, Hvidberg EF, Angelo H, Christensen MJ, Lous P. Influence of dextropropoxyphene on steady state serum levels and protein binding of three anti-epileptic drugs in man. Acta Neurol Scand. 1980;61:357–67.

    Article  PubMed  CAS  Google Scholar 

  8. Baker DK, Relling MV, Pui CH, Christensen ML, Evans WE, Rodman JH. Increased teniposide clearance with concomitant anticonvulsant therapy. J Clin Oncol. 1992;10:311–5.

    PubMed  CAS  Google Scholar 

  9. Gay PE, Madsen JA. Interaction between phenobarbital and thioridazine. Neurology. 1983;33:1631–2.

    Article  PubMed  CAS  Google Scholar 

  10. Bonaro S, Calgagno A, Fontana S, D’Avolio A, Siccardi M, Gobbi F, Di Perri G. Clinically significant interaction between tipranavir-ritonavir and phenobarbital in an HIV-infected patient. Clin Infect Dis. 2007;45:1654–5.

    Article  Google Scholar 

  11. Dravet C, Mesdjian E, Cenraud B, Roger J. Interaction between carbamazepine and triacetyloleandomycin. Lancet. 1997;1:810–1.

    Google Scholar 

  12. Bollini P, Riva R, Albani F, Ida N, Cacciari L, Bollini C, Baruzzi A. Decreased phenytoin level during antineoplastic therapy: a case report. Epilepsia. 1983;24:75–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Patsalos, P.N. (2013). Phenobarbital. In: Antiepileptic Drug Interactions. Springer, London. https://doi.org/10.1007/978-1-4471-2434-4_41

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2434-4_41

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2433-7

  • Online ISBN: 978-1-4471-2434-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics